Marks Group Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.51M | Sell |
28,826
-6,227
| -18% | -$543K | 0.23% | 107 |
|
2025
Q1 | $3.15M | Buy |
35,053
+441
| +1% | +$39.6K | 0.3% | 95 |
|
2024
Q4 | $2.76M | Buy |
34,612
+349
| +1% | +$27.9K | 0.27% | 100 |
|
2024
Q3 | $3.08M | Sell |
34,263
-87,561
| -72% | -$7.88M | 0.29% | 97 |
|
2024
Q2 | $9.59M | Buy |
121,824
+16,515
| +16% | +$1.3M | 1.01% | 14 |
|
2024
Q1 | $9.18M | Buy |
105,309
+4,410
| +4% | +$384K | 0.96% | 28 |
|
2023
Q4 | $8.31M | Sell |
100,899
-93
| -0.1% | -$7.66K | 0.95% | 20 |
|
2023
Q3 | $7.91M | Buy |
100,992
+139
| +0.1% | +$10.9K | 0.98% | 14 |
|
2023
Q2 | $8.89M | Buy |
100,853
+9,548
| +10% | +$841K | 1.06% | 11 |
|
2023
Q1 | $7.36M | Buy |
91,305
+5,298
| +6% | +$427K | 0.94% | 20 |
|
2022
Q4 | $6.68M | Buy |
86,007
+9
| +0% | +$699 | 0.91% | 28 |
|
2022
Q3 | $6.94M | Buy |
85,998
+3,571
| +4% | +$288K | 1.06% | 9 |
|
2022
Q2 | $7.4M | Buy |
82,427
+3,975
| +5% | +$357K | 1.07% | 10 |
|
2022
Q1 | $8.7M | Buy |
78,452
+9,629
| +14% | +$1.07M | 1.09% | 10 |
|
2021
Q4 | $7.13M | Buy |
68,823
+12,672
| +23% | +$1.31M | 0.87% | 22 |
|
2021
Q3 | $7.06M | Buy |
56,151
+4,383
| +8% | +$551K | 0.95% | 18 |
|
2021
Q2 | $6.42M | Buy |
51,768
+1,952
| +4% | +$242K | 0.88% | 17 |
|
2021
Q1 | $5.88M | Sell |
49,816
-739
| -1% | -$87.2K | 0.87% | 29 |
|
2020
Q4 | $5.92M | Buy |
50,555
+102
| +0.2% | +$11.9K | 0.92% | 23 |
|
2020
Q3 | $5.24M | Buy |
50,453
+6,864
| +16% | +$713K | 0.95% | 16 |
|
2020
Q2 | $3.99M | Buy |
43,589
+40,921
| +1,534% | +$3.75M | 0.81% | 56 |
|
2020
Q1 | $240K | Sell |
2,668
-300
| -10% | -$27K | 0.06% | 195 |
|
2019
Q4 | $337K | Buy |
+2,968
| New | +$337K | 0.07% | 195 |
|